BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36750485)

  • 21. Characterization of the fibrinolytic state by measuring stable cross-linked fibrin degradation products in disseminated intravascular coagulation associated with acute promyelocytic leukemia.
    Okajima K; Koga S; Okabe H; Inoue M; Takatsuki K
    Acta Haematol; 1989; 81(1):15-8. PubMed ID: 2494830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma fibrinogen, D-dimer, and fibrin degradation product as biomarkers of rheumatoid arthritis.
    Xue L; Tao L; Li X; Wang Y; Wang B; Zhang Y; Gao N; Dong Y; Xu N; Xiong C; Zhou T; Liu Z; Liu H; He J; Li K; Geng Y; Li M
    Sci Rep; 2021 Aug; 11(1):16903. PubMed ID: 34413382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
    Dombret H; Scrobohaci ML; Ghorra P; Zini JM; Daniel MT; Castaigne S; Degos L
    Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia.
    Ookura M; Hosono N; Tasaki T; Oiwa K; Fujita K; Ito K; Lee S; Matsuda Y; Morita M; Tai K; Negoro E; Kishi S; Iwasaki H; Ueda T; Yamauchi T
    Medicine (Baltimore); 2018 Nov; 97(44):e12981. PubMed ID: 30383650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absolute Circulating Leukemic Cells as a Risk Factor for Early Bleeding Events in Patients with Non-High-Risk Acute Promyelocytic Leukemia.
    Pei Y; Shi M; Song J; Niu X; Wei S; Dou L; Xiao M; Li D; Xu F; Bai Y; Sun K
    Cancer Manag Res; 2021; 13():4135-4146. PubMed ID: 34045900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levels of peripheral blood routine, biochemical and coagulation parameters in patients with hemorrhagic fever with renal syndrome and their relationship with prognosis: an observational cohort study.
    Chen WJ; Du H; Hu HF; Lian JQ; Jiang H; Li J; Chen YP; Zhang Y; Wang PZ
    BMC Infect Dis; 2024 Jan; 24(1):75. PubMed ID: 38212688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elastase mediated fibrinolysis in acute promyelocytic leukemia.
    Oudijk EJ; Nieuwenhuis HK; Bos R; Fijnheer R
    Thromb Haemost; 2000 Jun; 83(6):906-8. PubMed ID: 10896247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy evaluation of D-dimer and modified criteria in overt and nonovert disseminated intravascular coagulation diagnosis.
    Li WJ; Sha M; Ma W; Zhang ZP; Wu YJ; Shi DM
    Int J Lab Hematol; 2016 Apr; 38(2):151-9. PubMed ID: 26833979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features and treatment outcomes of six patients with disseminated intravascular coagulation resulting from acute promyelocytic leukemia and treated with recombinant human soluble thrombomodulin at a single institution.
    Kawano N; Kuriyama T; Yoshida S; Yamashita K; Ochiai H; Nakazaki S; Tasaki A; Ueda A
    Intern Med; 2013; 52(1):55-62. PubMed ID: 23291674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disseminated intravascular coagulation in acute leukemia: clinical and laboratory features at presentation.
    Yanada M; Matsushita T; Suzuki M; Kiyoi H; Yamamoto K; Kinoshita T; Kojima T; Saito H; Naoe T
    Eur J Haematol; 2006 Oct; 77(4):282-7. PubMed ID: 16856920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort.
    Matsushita T; Watanabe J; Honda G; Mimuro J; Takahashi H; Tsuji H; Eguchi Y; Kitajima I; Sakata Y
    Thromb Res; 2014 May; 133(5):772-81. PubMed ID: 24636871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Abnormality of blood coagulation indexes in patients with de novo acute leukemia and its clinical significance].
    Xiao FF; Hu KX; Guo M; Qiao JH; Sun QY; Ai HS; Yu CL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):300-4. PubMed ID: 23628020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin.
    Ikezoe T
    Int J Hematol; 2014 Jul; 100(1):27-37. PubMed ID: 24217998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preferential consumption of heparin cofactor II in disseminated intravascular coagulation associated with acute promyelocytic leukemia.
    Kario K; Matsuo T; Kodama K; Katayama S; Kobayashi H
    Thromb Res; 1992 May; 66(4):435-44. PubMed ID: 1412208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simplified predictive scores for thrombosis and bleeding complications in newly diagnosed acute leukemia patients.
    Owattanapanich W; Rungjirajittranon T; Jantataeme A; Kungwankiattichai S; Ruchutrakool T
    Thromb J; 2023 Jun; 21(1):65. PubMed ID: 37291589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antiplasmin drugs and factor XIII concentrates in the treatment of a patient with acute promyelocytic leukemia (M3)].
    Ryo R; Sugano W; Yoshida A; Adachi M; Yasunaga M; Yoneda N; Saigo K; Kondo S; Yamaguchi N; Nobusawa A
    Gan No Rinsho; 1989 Oct; 35(12):1479-82. PubMed ID: 2810783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Retrospective cohort study on the coagulation characteristics of adult patients with extensively severe burn in shock stage and its alarming value].
    Ma QM; Liu XB; Wu GS; Hou WJ; Fan XM; Shen T; Wang KA; Zhu F
    Zhonghua Shao Shang Za Zhi; 2021 Feb; 37(2):150-156. PubMed ID: 33498103
    [No Abstract]   [Full Text] [Related]  

  • 38. Advances in the management of coagulopathy in acute promyelocytic leukemia.
    Sanz MA; Montesinos P
    Thromb Res; 2020 Jul; 191 Suppl 1():S63-S67. PubMed ID: 32736781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic Value of Aortic Dissection Risk Score, Coagulation Function, and Laboratory Indexes in Acute Aortic Dissection.
    Song R; Xu N; Luo L; Zhang T; Duan H
    Biomed Res Int; 2022; 2022():7447230. PubMed ID: 35496052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical significance of monitoring coagulation- and fibrinolysis-related indexes during catheter-directed thrombolysis for acute lower-extremity deep venous thrombosis].
    Dong JY; Zhu QH; Luo MH; Zhou CY; Huang W; Yu XF
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 36(4):588-91. PubMed ID: 27113193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.